BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sorrento Therapeutics, Inc. 



San Diego  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Biotechnology






 Company News
Sorrento Therapeutics, Inc. Awarded Grant From The National Institutes of Health (NIH) For The Development Of A Small Molecule Myc Inhibitor 7/21/2014 1:05:19 PM
Sorrento Therapeutics, Inc. Awarded Grant From The National Institutes Of Health For The Development Of A Small Molecule Myc Inhibitor 7/21/2014 12:52:49 PM
Sorrento Therapeutics, Inc. Awarded Up To $2.6 Million From The National Institutes of Health (NIH) For The Development Of New Anti-Bacterial Bispecific Antibodies And Antibody Formulated Drug Conjugates 7/1/2014 11:13:06 AM
Morphotek Inc. And Sorrento Therapeutics, Inc. Sign An Exclusive Research And Option Agreement To Generate And Develop Morphotek Antibody Drug Conjugates 6/25/2014 7:04:46 AM
Sorrento Therapeutics, Inc. Announces Confidential Submission Of Draft Registration Statement For Initial Public Offering (IPO) Of Its Wholly-Owned Subsidiary Ark Animal Health With The SEC 6/23/2014 7:39:56 AM
Sorrento Therapeutics, Inc. To Present At Biotechnology Industry Organization (BIO) Business Forum 6/23/2014 6:24:46 AM
Sorrento Therapeutics, Inc. Announces Underwriters' Exercise Of Over-Allotment Option 6/13/2014 7:55:16 AM
Sorrento Therapeutics, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference 6/2/2014 6:23:39 AM
Sorrento Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock 5/14/2014 12:25:41 PM
Sorrento Therapeutics, Inc. Announces Transfer Of Orphan Drug Designation Sponsorship for Intrathecal Resiniferatoxin From National Institutes of Health (NIH) 5/13/2014 9:27:33 AM
1234567